Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
26.3M
-
Shares change
-
+1.68M
-
Total reported value, excl. options
-
$383M
-
Value change
-
+$30.8M
-
Put/Call ratio
-
0.04
-
Number of buys
-
40
-
Number of sells
-
-28
-
Price
-
$14.55
Significant Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2015
83 filings reported holding HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share as of Q1 2015.
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3M shares
of 183M outstanding shares and own 14.35% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5.01M shares), TANG CAPITAL MANAGEMENT LLC (4.92M shares), Broadfin Capital, LLC (2.81M shares), BAKER BROS. ADVISORS LP (2.61M shares), Cormorant Asset Management, LLC (1.27M shares), VHCP Management, LLC (1.1M shares), Allianz Asset Management AG (955K shares), Tekla Capital Management LLC (874K shares), MILLENNIUM MANAGEMENT LLC (676K shares), and VANGUARD GROUP INC (669K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.